» Articles » PMID: 30882208

Trapped! A Critical Evaluation of Methods for Measuring Total Cellular Uptake Versus Cytosolic Localization

Overview
Journal Bioconjug Chem
Specialty Biochemistry
Date 2019 Mar 19
PMID 30882208
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Biomolecules have many properties that make them promising for intracellular therapeutic applications, but delivery remains a key challenge because large biomolecules cannot easily enter the cytosol. Furthermore, quantification of total intracellular versus cytosolic concentrations remains demanding, and the determination of delivery efficiency is thus not straightforward. In this review, we discuss strategies for delivering biomolecules into the cytosol and briefly summarize the mechanisms of uptake for these systems. We then describe commonly used methods to measure total cellular uptake and, more selectively, cytosolic localization, and discuss the major advantages and drawbacks of each method. We critically evaluate methods of measuring "cell penetration" that do not adequately distinguish total cellular uptake and cytosolic localization, which often lead to inaccurate interpretations of a molecule's cytosolic localization. Finally, we summarize the properties and components of each method, including the main caveats of each, to allow for informed decisions about method selection for specific applications. When applied correctly and interpreted carefully, methods for quantifying cytosolic localization offer valuable insight into the bioactivity of biomolecules and potentially the prospects for their eventual development into therapeutics.

Citing Articles

DARPins as a novel tool to detect and degrade p73.

Munick P, Zielinski J, Strubel A, Gutfreund N, Dreier B, Schaefer J Cell Death Dis. 2024; 15(12):909.

PMID: 39695090 PMC: 11655841. DOI: 10.1038/s41419-024-07304-2.


pH-Responsive Peptide Nanoparticles Deliver Macromolecules to Cells via Endosomal Membrane Nanoporation.

Wu E, Ellis A, Bell K, Moss D, Landry S, Hristova K ACS Nano. 2024; 18(50):33922-33936.

PMID: 39651582 PMC: 11656837. DOI: 10.1021/acsnano.4c07525.


Protein degradation kinetics measured by microinjection and live-cell fluorescence microscopy.

Vukovic D, Winkelvoss D, Kapp J, Hanny A, Burgisser H, Riermeier L Sci Rep. 2024; 14(1):27153.

PMID: 39511251 PMC: 11544240. DOI: 10.1038/s41598-024-76224-0.


Cytosolic delivery of monobodies using the bacterial type III secretion system inhibits oncogenic BCR: ABL1 signaling.

Lebon C, Grossmann S, Mann G, Lindner F, Koide A, Koide S Cell Commun Signal. 2024; 22(1):500.

PMID: 39415233 PMC: 11483992. DOI: 10.1186/s12964-024-01874-6.


Plasma membrane damage limits cytoplasmic delivery by conventional cell penetrating peptides.

Polderdijk S, Limzerwala J, Spiess C PLoS One. 2024; 19(9):e0305848.

PMID: 39226290 PMC: 11371239. DOI: 10.1371/journal.pone.0305848.


References
1.
Zelphati O, Wang Y, Kitada S, Reed J, Felgner P, Corbeil J . Intracellular delivery of proteins with a new lipid-mediated delivery system. J Biol Chem. 2001; 276(37):35103-10. DOI: 10.1074/jbc.M104920200. View

2.
Li Y, Rodewald L, Hoppmann C, Wong E, Lebreton S, Safar P . A versatile platform to analyze low-affinity and transient protein-protein interactions in living cells in real time. Cell Rep. 2014; 9(5):1946-1958. PMC: 4269221. DOI: 10.1016/j.celrep.2014.10.058. View

3.
Stevenson C, Augustijns P, Hendren R . Use of Caco-2 cells and LC/MS/MS to screen a peptide combinatorial library for permeable structures. Int J Pharm. 1999; 177(1):103-15. DOI: 10.1016/s0378-5173(98)00331-7. View

4.
Vasconcelos L, Lehto T, Madani F, Radoi V, Hallbrink M, Vukojevic V . Simultaneous membrane interaction of amphipathic peptide monomers, self-aggregates and cargo complexes detected by fluorescence correlation spectroscopy. Biochim Biophys Acta Biomembr. 2017; 1860(2):491-504. DOI: 10.1016/j.bbamem.2017.09.024. View

5.
Pichon C, Monsigny M, Roche A . Intracellular localization of oligonucleotides: influence of fixative protocols. Antisense Nucleic Acid Drug Dev. 1999; 9(1):89-93. DOI: 10.1089/oli.1.1999.9.89. View